Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 14:45 ET | Source: Tevogen Bio Inc

Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn

Tevogen clarifies GAAP-reported deficit, citing strong capital efficiency, low cash burn, and plans to share reconciled non-GAAP metrics.
November 03, 2025 08:05 ET | Source: Candel Therapeutics

Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London

NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...
November 03, 2025 07:00 ET | Source: Abpro Corporation

Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025

Achieved ~60% reduction in operating costs through a focused cost optimization plan DiversImmune® platform positioned to unlock additional pipeline value Reverse stock split supports Nasdaq...
November 03, 2025 06:37 ET | Source: Research and Markets

Molecular Diagnostics for Cancer Markets Forecasts 2025-2030: Accelerated Growth Driven by Trends Like Personalized Medicine, Pharmacogenomics, and Liquid Biopsy

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides and Impact of Artificial...
October 30, 2025 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of...
October 30, 2025 07:41 ET | Source: Research and Markets

United States Cancer Immunotherapy Forecast Report 2025: A $71.65 Billion Market by 2033, Driven by Digital Transformation, AI Adoption, Cloud Demand, and Growth of Mobile and Web Applications

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "United States Cancer Immunotherapy Market Report by Products, Application, End User, States and Company Analysis, 2025-2033" report has been added to ...
October 29, 2025 13:22 ET | Source: Research and Markets

Cancer Immunotherapy Market Size and Share Analysis: Growth Trends and Forecast Report 2025-2033

Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's...
October 29, 2025 12:35 ET | Source: Tevogen Bio Inc

Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress

WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to...
October 27, 2025 07:00 ET | Source: https://immatics.com/

Immatics Appoints Amie Krause as Chief People Officer

Houston, Texas and Tuebingen, Germany, October 27, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision...
October 22, 2025 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine

SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of...